Schering Claritin ads referring to Seldane proposed withdrawal must mention Allegra -- court order.
Executive Summary
SCHERING CLARITIN ADS MUST INCLUDE MENTION OF ALLEGRA if they are to refer to FDA's proposed withdrawal of Hoechst Marion Roussel's Seldane (terfenadine), Kansas City federal court judge Nanette Laughrey stated in a Feb. 10 temporary restraining order. Laughrey issued the TRO in response to a complaint filed by HMR Feb. 7.